Related references
Note: Only part of the references are listed.Berberine Attenuates Cholesterol Accumulation in Macrophage Foam Cells by Suppressing AP-1 Activity and Activation of the Nrf2/HO-1 Pathway
Xue-Juan Yang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Apolipoprotein M: new connections with diet, adipose tissue and metabolic syndrome
Genevieve Tavernier et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance
Hamed Mortazavi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
HDL and Reverse Cholesterol Transport Basic Mechanisms and Their Roles in Vascular Health and Disease
Mireille Ouimet et al.
CIRCULATION RESEARCH (2019)
Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C δ pathway
Hui Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients
Xiaojiang Zhan et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Ju Jianqing et al.
PHYTOMEDICINE (2018)
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Arrigo F. G. Cicero et al.
NUTRITION REVIEWS (2017)
Regulation of PCSK9 by nutraceuticals
Amir Abbas Momtazi et al.
PHARMACOLOGICAL RESEARCH (2017)
HDL abnormalities in familial hypercholesterolemia: Focus on biological functions
Shiva Ganjali et al.
PROGRESS IN LIPID RESEARCH (2017)
SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis
MacRae F. Linton et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo controlled study
Sergio D'Addato et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Regulatory effects of berberine on microRNome in Cancer and other conditions
Seyed Hasan Ayati et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
Magdalena Rysz-Gorzynska et al.
ARCHIVES OF MEDICAL SCIENCE (2016)
The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Xiaoyun Wei et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
The antihypercholesterolemic effect of columbamine from Rhizoma Coptidis in HFHC-diet induced hamsters through HNF-4α/FTF-mediated CYP7A1 activation
Yue Wang et al.
FITOTERAPIA (2016)
Hypolipidemic Effects of Alkaloids from Rhizoma Coptidis in Diet-Induced Hyperlipidemic Hamsters
Kai He et al.
PLANTA MEDICA (2016)
Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials
Jesus Millan et al.
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS (2016)
Current knowledge and pharmacological profile of berberine: An update
Anil Kumar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles
Mike Mackness et al.
GENE (2015)
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
Jiarong Lan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
Tomas Vaisar et al.
JOURNAL OF LIPID RESEARCH (2015)
Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters
Xiao-Yang Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine
Shenghua Gu et al.
MOLECULAR BIOSYSTEMS (2015)
High-density lipoprotein synthesis and metabolism (Review)
Lingyan Zhou et al.
MOLECULAR MEDICINE REPORTS (2015)
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications
Bodo Levkau
FRONTIERS IN PHARMACOLOGY (2015)
Inhibition of proprotein convertase subtilisin/kexin type 9: A novel mechanism of berberine and 8-hydroxy dihydroberberine against hyperlipidemia
Liu De-liang et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2015)
The Safety and Anti-Hypercholesterolemic Effect of Coptisine in Syrian Golden Hamsters
Kai He et al.
LIPIDS (2015)
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality
Marcin Barylski et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption
Yanwen Wang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Effects of Poly-Bioactive Compounds on Lipid Profile and Body Weight in a Moderately Hypercholesterolemic Population with Low Cardiovascular Disease Risk: A Multicenter Randomized Trial
Rosa Sola et al.
PLOS ONE (2014)
Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients A Meta-Analysis
S. Matthijs Boekholdt et al.
CIRCULATION (2013)
Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats
Feng Ling Wang et al.
MOLECULAR BIOLOGY REPORTS (2013)
On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: Impact on carotid intima-media thickness
Matteo Pirro et al.
LIFE SCIENCES (2013)
HDL functionality
Handrean Soran et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Berberine-induced inhibition of adipocyte enhancer-binding protein 1 attenuates oxidized low-density lipoprotein accumulation and foam cell formation in phorbol 12-myristate 13-acetate-induced macrophages
Zhouqing Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet
Xin-xia Chang et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Lipid-lowering effect of berberine in human subjects and rats
Yueshan Hu et al.
PHYTOMEDICINE (2012)
Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor Pathway in Experimental Diabetic Nephropathy Models
Kaipeng Huang et al.
PLOS ONE (2012)
Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
Aneta Otocka-Kmiecik et al.
PROGRESS IN LIPID RESEARCH (2012)
Berberine-Improved Visceral White Adipose Tissue Insulin Resistance Associated with Altered Sterol Regulatory Element-Binding Proteins, Liver X Receptors, and Peroxisome Proliferator-Activated Receptors Transcriptional Programs in Diabetic Hamsters
Guo-Sheng Li et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells
Chi-Chih Cheng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides
Qian Zhang et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Biological activities of HDL subpopulations and their relevance to cardiovascular disease
Laurent Camont et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Effects of Berberine on Expression of LOX-1 and SR-BI in Human Macrophage-Derived Foam Cells Induced by ox-LDL
Siming Guan et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2010)
被撤回的出版物: Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway (Retracted article. See vol. 742, 2023)
Tian Lan et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
Margarita de la Llera-Moya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters
Yanwen Wang et al.
ATHEROSCLEROSIS (2010)
The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway
Daniella M. Oosterveer et al.
EUROPEAN HEART JOURNAL (2010)
Berberine inhibits adipogenesis in high-fat diet-induced obesity mice
Yueshan Hu et al.
FITOTERAPIA (2010)
Anti-Atherogenic Effect of Berberine on LXRα-ABCA1-Dependent Cholesterol Efflux in Macrophages
Tzong-Shyuan Lee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
A systematic review and meta-analysis on the therapeutic equivalence of statins
T. -C. Weng et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
HDL-paraoxonase and Membrane Lipid Peroxidation: A Comparison Between Healthy and Obese Subjects
Gianna Ferretti et al.
OBESITY (2010)
The LDL Receptor
Joseph L. Goldstein et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations
Jun Tang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
The role of dysfunctional HDL in atherosclerosis
Mohamad Navab et al.
JOURNAL OF LIPID RESEARCH (2009)
The HDL proteome: a marker-and perhaps mediator-of coronary artery disease
Jay W. Heinecke
JOURNAL OF LIPID RESEARCH (2009)
Berberine Analogues as a Novel Class of the Low-Density-Lipoprotein Receptor Up-Regulators: Synthesis, Structure-Activity Relationships, and Cholesterol-Lowering Efficacy
Ying-Hong Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Lecithin: cholesterol acyltransferase - from biochemistry to role in cardiovascular disease
Xavier Rousset et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats
Ji Yin Zhou et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Increased oxidative stress in scavenger receptor BI knockout mice with dysfunctional HDL
Miranda Van Eck et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
Brian J. Van Lenten et al.
JOURNAL OF LIPID RESEARCH (2007)
The roles of different pathways in the release of cholesterol from macrophages
Maria Pia Adorni et al.
JOURNAL OF LIPID RESEARCH (2007)
Minimal lipidation of pre-β HDL by ABCA1 results in reduced ability to interact with ABCA1
Anny Mulya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients
Jeroen van Wijk et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Molecular regulation of HDL metabolism and function: implications for novel therapies
Daniel J. Rader
JOURNAL OF CLINICAL INVESTIGATION (2006)
Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation
A Majdalawieh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease
L Pasqualini et al.
ATHEROSCLEROSIS (2005)
Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine
P Abidi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
The anti-inflammatory potential of berberine in vitro and in vivo
CL Kuo et al.
CANCER LETTERS (2004)
Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons:: Support for the amyloid hypothesis
TD Stein et al.
JOURNAL OF NEUROSCIENCE (2004)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
HDL: The metabolism, function, and therapeutic importance
MH Wang et al.
CHEMICAL REVIEWS (2004)
Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver
M Van Eck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Antioxidant paraoxonase 1 activity in the metabolic syndrome
M Senti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux
TE Akiyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
A Chawla et al.
MOLECULAR CELL (2001)
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
A Venkateswaran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
